Lido Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-33,469
| Closed | -$1.51M | – | 1343 |
|
|
2024
Q3 | $1.51M | Sell |
33,469
-3,992
| -11% | -$180K | 0.01% | 513 |
|
|
2024
Q2 | $1.56M | Sell |
37,461
-32,682
| -47% | -$1.36M | 0.01% | 474 |
|
|
2024
Q1 | $3.19M | Sell |
70,143
-4,810
| -6% | -$219K | 0.02% | 323 |
|
|
2023
Q4 | $3.47M | Sell |
74,953
-13,858
| -16% | -$641K | 0.02% | 298 |
|
|
2023
Q3 | $3.61M | Buy |
88,811
+6,447
| +8% | +$262K | 0.03% | 273 |
|
|
2023
Q2 | $3.99M | Buy |
82,364
+1,372
| +2% | +$66.5K | 0.03% | 239 |
|
|
2023
Q1 | $3.99M | Buy |
80,992
+471
| +0.6% | +$23.2K | 0.04% | 223 |
|
|
2022
Q4 | $4.07M | Buy |
+80,521
| New | +$4.07M | 0.05% | 183 |
|